News

If you're looking for reasonably priced stocks to pick up right now, you shouldn't overlook Pfizer (NYSE: PFE). The pharmaceutical giant isn't as risky an investment as it may appear to be. Its

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons it is home to solid dividend stocks, including Pfizer (NYSE: PFE) and

Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable healthcare company in the world, with a market cap of $730 billion.

The

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount bin. However, even in a bull market, like the one we're currently

Buying low to sell later when the stock's price is high is a time-honored investing strategy. With the benchmark S&P 500 index near its all-time high, though, now might seem like the wrong time to

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on U.S. stock exchanges.

However, three Motley Fool contributors think they can make the

Buying quality stocks when they're unpopular can be very rewarding.

A good place to look for unpopular stocks these days is in the healthcare sector, as Robert F. Kennedy Jr.'s nomination and

There are many ways to make money on Wall Street, but some methods are a lot more reliable than others. Whether you're looking for a way to raise the stream of passive income your portfolio produces

The U.S. Department of Justice has reportedly launched an investigation into UnitedHealth Group's (NYSE: UNH) Medicare billing practices.

Investors were shaken by the report, sending UnitedHealth

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent times. Thanks to its coronavirus treatment and vaccine, the pharma giant

Investing in a top healthcare company whose share price has been tanking in recent years could present a huge opportunity for investors, especially when that company has been bolstering its growth

The past three years have been difficult for Pfizer (NYSE: PFE). The pharmaceutical giant's financial results worsened substantially as its coronavirus-related tailwind came to a screeching halt

Image source: The Motley Fool.

Pfizer (NYSE: PFE)Q4 2024 Earnings CallFeb 04, 2025, 10:30 a.m. ET

Operator

Continue reading

Source Fool.com

Pharmaceuticals giant Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings

Dividend stocks can be a great way to boost your portfolio's growth potential or provide a form of passive income over the years. While not all dividend stocks are the same, finding great companies

If you're a new investor, want some recurring dividend income, or just want some top stocks to build your portfolio around, it's important to focus on businesses with strong fundamentals and room to

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. But since that notable achievement, its financial results have fallen

Pharmaceutical giant Pfizer (NYSE: PFE) is trading near its lowest price in over a decade.

The company's revenue and profits ballooned during the pandemic on its COVID-19 vaccine and treatment. Then

How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever. Its highest mark came in early 2000 before the dot-com bubble burst. The

Image source: The Motley Fool.

UnitedHealth Group (NYSE: UNH)Q4 2024 Earnings CallJan 16, 2025, 8:45 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of UnitedHealth Group (NYSE: UNH) were pulling back Thursday after the company delivered underwhelming fourth-quarter results, as sales were weaker than expected and its costs rose.

 As of

Medicine is the cornerstone of healthcare. That remains true today, with a global pharmaceutical industry valued at $1.4 trillion and expected to grow at 6.1% annually through 2030. In this light

If you're looking for a top dividend stock to own, you want to be sure to consider whether it increases its payout and keep track of how quickly it normally does so. The rate of increases can be key

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company.

*Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on

With shares of the popular dividend exchange-traded fund (ETF) Schwab US Dividend Equity ETF (NYSEMKT: SCHD), investors are wondering whether it is time to dump the ETF or double up. In today's